Home / Resources / Medicare GLP-1 Bridge

The July 2026 decoder

The Medicare GLP-1 Bridge, decoded

Starting July 1, 2026, Medicare covers certain GLP-1 weight-management drugs for a flat $50 a month under a temporary program called the Medicare GLP-1 Bridge. It is real, it is nationwide, and its first week has been genuinely confusing at the pharmacy counter. Here is who qualifies, how the billing actually works, and what to do when a claim bounces.

Go to the pharmacy checklist My claim was rejected

Accurate as of July 5, 2026. Every fact on this page is tied to CMS or Medicare.gov guidance, listed in the sources at the end. The program is new and guidance is still being updated; where something has not been published yet, we say so plainly. This is general information about a federal program, not medical or legal advice.

The Bridge launched with its own billing rails, its own eligibility rules, and its own prior authorization process, none of which match how your Part D plan works. Pharmacy and prior-auth staff describe spending launch week rerouting Bridge prescriptions that were sent to the wrong payer. Patients are walking away from the counter believing they were denied when the claim simply needed to be routed correctly. Most first-week failures are process errors with known fixes. This page is the decoder.

What changed on July 1

The Medicare GLP-1 Bridge is a short-term demonstration run by CMS from July 1, 2026 through December 31, 2027, available nationwide in all states and territories (per the CMS Medicare GLP-1 Bridge FAQ, updated July 1, 2026). For eligible people with Medicare drug coverage, it provides:

  • Three covered drugs, for weight management only: Foundayo (tablets), Wegovy (injection and tablets), and Zepbound in the KwikPen only. Zepbound single-dose vials and single-dose pens are not covered (per CMS; the product list may be updated during the demonstration).
  • A flat $50 copay for each monthly fill, defined as a 28-or-30-day supply. Sixty and ninety day fills are not available under the Bridge (per CMS).
  • One prior authorization that lasts. Once approved, the prior authorization is valid through December 31, 2027, including refills and dose changes, unless you switch to a different covered GLP-1 (per CMS and Medicare.gov).

The single most important fact: the Bridge is not your Part D plan. It operates outside the Part D benefit entirely. Claims go to a central processor (CMS is using Humana, the administrator of the LI NET program) on the Bridge's own billing codes, and they are billed with your Medicare Number, the one on your red, white, and blue Medicare card, not your Part D plan member ID. Handing the pharmacy your drug-plan card for a Bridge fill is the most common way this goes sideways.

Because the Bridge sits outside Part D, the normal money plumbing does not apply (per the CMS FAQ and the CMS Pharmacy Fact Sheet, June 2026):

  • The $50 does not count toward your Part D deductible or annual out-of-pocket maximum.
  • Extra Help (the low-income subsidy) does not reduce it; the copay is $50 even for LIS beneficiaries.
  • It is not eligible for the Medicare Prescription Payment Plan, and manufacturer coupons or discount cards cannot be applied to Bridge claims.

Do not pay cash expecting reimbursement. The Bridge accepts electronic pharmacy claims only. CMS states that paper claims and direct member reimbursement will not be accepted, so there is no pay-out-of-pocket-now, file-for-repayment-later path. If a claim will not go through, the fix happens at the counter or with your prescriber, not on a reimbursement form.

Behind the scenes, participating manufacturers supply the covered drugs at a $245 net price per monthly supply and pharmacies are reimbursed at the drug's wholesale acquisition cost plus a small dispensing fee (per CMS). You never touch those numbers; your share is the flat $50.

Who qualifies

Eligibility has two tests, your plan and your clinical picture, plus one routing rule that trips people up. All three come from the CMS Bridge FAQ (updated July 1, 2026).

1. The plan test

You must be enrolled in Medicare drug coverage in an eligible plan type in 2026: a standalone prescription drug plan (PDP) or a Medicare Advantage coordinated care plan with drug coverage (HMO, HMO-POS, or local or regional PPO). Special Needs Plans, employer or union group waiver plans, and the LI NET program count. People in private fee-for-service plans, 1876 cost plans, health care prepayment plans, PACE, fallback plans, or religious fraternal benefit plans are not eligible unless they also have a standalone PDP. Dually eligible beneficiaries qualify if they are in an eligible plan type and meet the clinical criteria.

2. The clinical test

You must be 18 or older, using the drug to reduce excess body weight and keep it off, together with ongoing lifestyle changes (structured nutrition and physical activity), and meet one of three tiers at the time you started GLP-1 therapy:

  • ABMI 35 or higherNo additional diagnosis required.
  • BBMI 30 or higher, plus one of:heart failure with preserved ejection fraction; uncontrolled hypertension (above 140 systolic or 90 diastolic despite two blood-pressure medications); or chronic kidney disease stage 3a or above.
  • CBMI 27 or higher, plus one of:prediabetes (by American Diabetes Association definition); a previous heart attack; a previous stroke; or peripheral artery disease with symptoms.

Since the tier C conditions qualify at any BMI of 27 or above, Medicare.gov's plain-language version also lists prediabetes, prior heart attack or stroke, and symptomatic peripheral artery disease as qualifying in the 30 to 34.9 range.

The BMI clock runs from when you started the drug, not from today. CMS's own example: someone who began GLP-1 therapy in September 2024 at a BMI of 37 and is at 34 by July 2026 still qualifies under the BMI 35 tier, because the criteria are measured at initiation, even if that was before Medicare or before the Bridge existed. Your prescriber attests to this on the prior authorization, so a chart note documenting your starting BMI and its date is the load-bearing document. Keep it handy.

3. The routing rule

Some diagnoses route you to your Part D plan instead, no matter your BMI. If your GLP-1 is prescribed for type 2 diabetes, moderate to severe obstructive sleep apnea, noncirrhotic MASH (fatty liver disease with scarring), or to reduce the risk of major cardiovascular events with established heart disease, those uses are covered under Part D, and CMS says you are ineligible for the Bridge even if you otherwise meet its criteria (per the CMS FAQ and the Bridge prior authorization form). You are also ineligible if you already receive a GLP-1 covered by your Part D plan; if you have a clinical reason to want a different product than your plan covers, CMS points to your plan's formulary exception process, which is regular Part D territory with regular appeal rights.

The pharmacy-counter checklist

The launch-week confusion concentrates in three places: which card gets billed, what has to be on the prescription, and what the first rejection means. Here is the whole flow.

Bring these

  • Your red, white, and blue Medicare card. The Bridge bills your Medicare Number (MBI), not your drug-plan ID. If you cannot find the card, the pharmacy can look your Medicare Number up with your name, date of birth, and the last 4 digits of your Social Security number (per the CMS Pharmacy Fact Sheet).
  • Your Part D plan card too, so the pharmacy can confirm which payer is which. Just expect it not to be the card the Bridge claim runs on.
  • Patience for one bounce. The first claim is expected to reject for prior authorization. That is the program working, not you being denied.

What your prescriber puts on the prescription

Per the CMS Pharmacy Fact Sheet, a prescriber who believes you qualify should include an obesity diagnosis code from the E66 family on the prescription and indicate "SEND TO BRIDGE FOR WEIGHT MANAGEMENT" in the note field (or as an annotation on a paper script). A vague diagnosis will not route; pharmacy staff report scripts arriving with codes like "abnormal weight gain" and failing. The prior authorization form itself maps BMI at initiation to the codes: E66.811 for BMI 30 to 34.9, E66.812 for 35 to 39.9, and E66.813 for 40 and above.

What to say at the counter

Script one, routing: "This should go to the Medicare GLP-1 Bridge, not my Part D plan. The Bridge has its own BIN and PCN, 028918 and MEDDGLP1BR, and it bills my Medicare Number, not my plan member ID."

Script two, the expected bounce: "If it rejects asking for prior authorization, I understand that is the normal first step. Could you send the prior authorization request to my prescriber today?"

The expected first-fill sequence

  • 1Your prescriber sends the prescriptionwith the E66-family diagnosis code and the "send to Bridge" note, for a covered product (remember: Zepbound KwikPen only).
  • 2The pharmacy submits the claim to the Bridgeon BIN 028918 / PCN MEDDGLP1BR, billed with your Medicare Number.
  • 3The first claim rejects: "prior authorization required."By design, a rejected Bridge claim must exist before your prescriber can submit the prior authorization request (per the CMS prior authorization form). You have not been denied.
  • 4Your prescriber submits the prior authorization,electronically through CoverMyMeds or by fax to 1-800-530-2404. CMS says approval or denial should come within 72 hours; pharmacy staff report complete electronic submissions clearing in minutes, but plan on the 72-hour window. Both you and your prescriber are notified either way.
  • 5The pharmacy reruns the claim and you pay $50.You will also get a letter in the mail confirming your drug is covered under the Bridge (per Medicare.gov). The approval then covers refills and dose changes through December 31, 2027, unless you switch drugs.

One refill note: the Bridge will reject a refill as too soon until at least 75% of your last fill's days supply has passed (per the CMS reject code reference tool). If you are planning around travel, tell the pharmacy; they can time the submission.

Who to call

  • You: 1-800-MEDICARE (1-800-633-4227), TTY 1-877-486-2048, for eligibility and prior authorization status. The eligibility checker lives at Medicare.gov/glp1bridge.
  • Your pharmacy: the Bridge Pharmacy Help Desk, 844-673-0910, for claim submission problems.
  • Your prescriber: the Bridge Call Center, 855-273-0102, weekdays 8 am to 7 pm ET, for prior authorization questions.

If the claim rejects

Every Bridge rejection comes back with a reject code and a message to the pharmacy, and CMS published a troubleshooting reference for all of them (the Pharmacy Reject Code Reference Tool, June 2026). These are the ones people are actually hitting, and the fix for each:

  • 75"Prior authorization required"The designed first stop, not a dead end. Ask the pharmacy to kick the request to your prescriber the same day; the prescriber files through CoverMyMeds or by fax.
  • 70"Product not covered under GLP-1 Bridge"The prescribed formulation is not on the Bridge list, most often Zepbound single-dose vials or pens. Fix: the prescription is rewritten for the Zepbound KwikPen or another covered product.
  • 65"Patient is not covered"A family of causes: not enrolled in Part D on the fill date, enrolled in a plan type the Bridge excludes, or the system shows you already receiving a GLP-1 through your Part D plan. Fixes: verify the Medicare Number is current and correct; confirm your plan type; and if you were blocked because your plan already covers a GLP-1 but you need a different product for clinical reasons, that request goes to your plan as a formulary exception, not to the Bridge.
  • 52"Beneficiary not found"The claim was billed with the wrong ID: a Part D member ID, an old HICN, or an outdated Medicare Number. Fix: bill the current MBI from your newest Medicare card, or have the pharmacy run an eligibility lookup with your last 4 SSN.
  • 76"Plan limitations exceeded"More than a monthly supply, or the wrong quantity or strength for the dose. Fix: resubmit as a single 28-or-30-day fill in the standard package size.
  • 79"Refilled too soon"Resubmit once at least 75% of the previous fill's days supply has been used.

If the counter is stuck and the reject message does not make sense, the pharmacy-side fix is usually one call away: the Bridge Pharmacy Help Desk at 844-673-0910 exists for exactly this.

When it becomes a formal appeal

Most Bridge failures so far are routing and paperwork errors, fixable at the counter or with one prescriber phone call. They are not appeals, and treating them like appeals wastes weeks. But two situations do cross into formal territory, and one sits in a genuine gray zone.

The gray zone: a denied Bridge prior authorization

Honest status: the Bridge runs outside Part D, and as of July 5, 2026 CMS has not published a formal appeals process for Bridge prior authorization denials on its Bridge pages. What CMS has said: both you and your prescriber are notified of a denial with a reason. The productive paths today are fixing the underlying issue, most often documentation of your BMI at the time you started therapy or of a qualifying diagnosis, and having your prescriber call the Bridge Call Center (855-273-0102) to resolve or resubmit. We will update this page as CMS publishes more.

Where formal appeal rights clearly exist

  • Your GLP-1 is for a Part D-covered use and your plan denied it. Type 2 diabetes, moderate to severe sleep apnea, MASH, and cardiovascular risk reduction route through your Part D plan, and a plan denial there triggers the standard Medicare coverage determination and appeals process, with deadlines.
  • You need a different GLP-1 than your plan covers. If the Bridge turned you away because your Part D plan already covers a GLP-1 for you, and there is a clinical reason the covered one does not work, that is a formulary exception request to your plan. A denied exception is appealable through the same Part D ladder.

If you are holding one of those Part D denial letters, that is the paperwork Appealit exists for: we read the denial, tell you exactly why the plan said no, and draft the appeal with every citation verified, free. Start at appeal-odds whenever you are ready.

And if your doctor's office is hard to pin down, our provider request note helps you collect the exact chart items, starting BMI with its date, qualifying diagnoses, prior medications, that both the Bridge prior authorization and any appeal lean on.

Sources

Everything above traces to these documents, all public. Last checked July 5, 2026.

  1. CMS, Medicare GLP-1 Bridge (program FAQ), page updated July 1, 2026.
  2. CMS, Medicare GLP-1 Bridge: Information for Pharmacies, page updated July 1, 2026.
  3. CMS, Medicare GLP-1 Bridge: Information for Providers, page updated July 1, 2026.
  4. CMS, Medicare GLP-1 Bridge Pharmacy Fact Sheet, CMS Product No. 12236, June 2026 (PDF).
  5. CMS, Medicare GLP-1 Bridge Prior Authorization Request Form (PDF).
  6. CMS/NCPDP, Medicare GLP-1 Bridge Pharmacy Reject Code Reference Tool, June 2026 (PDF).
  7. CMS, GLP-1 Bridge Payer Sheet, effective July 1, 2026 (PDF).
  8. Medicare.gov, Weight loss drugs (Medicare GLP-1 Bridge), including the eligibility checker.
  9. CMS, Medicare GLP-1 Bridge: Information for Part D Plans (the $245 manufacturer net price).
  10. CMS press release, "Coming Soon: CMS to Provide $50 Monthly Access to GLP-1 Medications for Medicare Beneficiaries", May 6, 2026.

Common questions

Is the Medicare GLP-1 Bridge part of my Part D plan?
No. The Bridge is a separate, temporary CMS demonstration that runs outside your Part D plan's coverage and payment flow. Claims go to a central processor on the Bridge's own BIN and PCN (028918 and MEDDGLP1BR) and are billed with your Medicare Number, not your plan member ID. The $50 copay does not count toward your Part D deductible or out-of-pocket maximum, per CMS guidance updated July 1, 2026.
Can I use the Bridge if I have type 2 diabetes?
No. If your GLP-1 is prescribed for type 2 diabetes, moderate to severe obstructive sleep apnea, MASH (fatty liver disease with scarring), or to reduce cardiovascular event risk with established heart disease, coverage belongs with your Part D plan, and CMS says you are ineligible for the Bridge even if you meet its BMI criteria.
Why did my first Bridge claim reject at the pharmacy?
Usually because prior authorization is required, and under the program's design the first claim must reject before your prescriber can submit the prior authorization request. That first rejection is the expected flow, not a denial of you. Your prescriber submits the PA electronically through CoverMyMeds or by fax, and CMS says the decision should come within 72 hours.
Does Extra Help lower the $50 Bridge copay?
No. Because the Bridge sits outside the Part D benefit, the low-income subsidy (Extra Help) does not apply, the copay cannot go on the Medicare Prescription Payment Plan, and manufacturer coupons or discount cards cannot be used on Bridge claims, per CMS.
Which GLP-1 drugs does the Bridge cover?
Foundayo (tablets), Wegovy (injection and tablets), and Zepbound in the KwikPen only, when prescribed to reduce excess body weight and maintain weight reduction. Zepbound single-dose vials and single-dose pens are not covered, per CMS. The covered product list may be updated during the demonstration.

Keep reading: The provider request note · How to appeal a GLP-1 denial · Internal vs external review · All resources